Evaluation of a new vessel imaging system to support venous cannulation in children prior to elective, non-cardiac surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24014

Enrollment

400

Registered

2010-04-08

Start date

2010-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vessel visualization, Venipuncture, VascuLuminator, infrared, Venous cannulation, infrarood, bloedvaten, veneus infuus

Interventions

The VascuLuminator is the investigational product in this study. It is able to non-invasively visualize blood vessels by means of near-infrared light. The intervention consists of the use of the devi

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients aged less than 18 years, undergoing elective, non-cardiac surgery, will be included in the present trial.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
The main study parameter is the percentage of procedures in which more than one puncture is required for successful venous cannulation (i.e. failure rate).	—

Secondary

Measure	Time frame
1. Secondary parameters will be the number of punctures and the duration of the procedure. The duration of the procedure starts at the moment the first attempt is made to search for a suitable vessel, by palpating or looking (with the system in use, looking with the system) and ends at the moment the line is flushed; 2. Patient characteristics such as skin color, length and weigth and age, are measured.	—

Measure

Time frame

1. Secondary parameters will be the number of punctures and the duration of the procedure. The duration of the procedure starts at the moment the first attempt is made to search for a suitable vessel, by palpating or looking (with the system in use, looking with the system) and ends at the moment the line is flushed; 2. Patient characteristics such as skin color, length and weigth and age, are measured.

—

Contacts

Public ContactNatascha Cuper

Mailstop C.01.230 P.O. Box 85500

n.j.cuper@umcutrecht.nl+31(0)88 755 3243

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)